Pretreatment of Adipose Derived Stem Cells with Curcumin Facilitates Myocardial Recovery via Antiapoptosis and Angiogenesis

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Liu, Jianfeng ^a   Zhu, Ping ^a   Song, Peng ^a   Xiong, Weiping ^b   Chen, Haixu ^a   Peng, Wenhui ^c   Wang, Shuxia ^a   Li, Shan ^a   Fu, Zhiqing ^a   Wang, Yutang ^a   Wang, Haibin ^d  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Shanghai Changning Center Hospital   (China)

^c TONGJI UNIVERSITY   (China)

^d BEIJING JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; HYDROGEN PEROXIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE; PROTEIN P53; VASCULOTROPIN;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; STEM CELL TRANSPLANTATION;

RATTUS;

EID: 84930011780     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/638153     Document Type: Article

References (39)

1. S. Čarnická, A. Adameová, M. Nemčeková, J. Matejíková, D. Pancza, and T. Ravingerová, "Distinct effects of acute pretreatment with lipophilic and hydrophilic statins on myocardial stunning, arrhythmias and lethal injury in the rat heart subjected to ischemia/reperfusion," Physiological Research, vol. 60, no. 5, pp. 825-830, 2011.
2. D. M. Yellon and D. J. Hausenloy, "Myocardial reperfusion injury," The New England Journal of Medicine, vol. 357, no. 11, pp. 1074-1135, 2007.
3. K. Kikuchi and K. D. Poss, "Cardiac regenerative capacity and mechanisms," Annual Review of Cell and Developmental Biology, vol. 28, pp. 719-741, 2012.
4. M. Gnecchi, P. Danieli, and E. Cervio, "Mesenchymal stem cell therapy for heart disease," Vascular Pharmacology, vol. 57, no. 1, pp. 48-55, 2012.
5. J. Tongers, D. W. Losordo, and U. Landmesser, "Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges," European Heart Journal, vol. 32, no. 10, pp. 1197-1206, 2011.
6. M. Gnecchi, Z. Zhang, A. Ni, and V. J. Dzau, "Paracrine mechanisms in adult stem cell signaling and therapy," Circulation Research, vol. 103, no. 11, pp. 1204-1219, 2008.
7. A. R. Williams and J. M. Hare, "Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease," Circulation Research, vol. 109, no. 8, pp. 923-940, 2011.
8. L. Deng, G. Liu, X. Wu et al., "Adipose derived mesenchymal stem cells efficiently rescue carbon tetrachloride-induced acute liver failure in mouse," The Scientific World Journal, vol. 2014, Article ID 103643, 8 pages, 2014.
9. M. Aguena, R. Dalto Fanganiello, L. A. L. Tissiani et al., "Optimization of parameters for a more efficient use of adipose-derived stem cells in regenerative medicine therapies," Stem Cells International, vol. 2012, Article ID 303610, 7 pages, 2012.
10. L. E. Kokai, K. Marra, and J. P. Rubin, "Adipose stem cells: biology and clinical applications for tissue repair and regeneration," Translational Research, vol. 163, no. 4, pp. 399-408, 2014.
11. H. K. Haider and M. Ashraf, "Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation," Journal of Molecular and Cellular Cardiology, vol. 45, no. 4, pp. 554-566, 2008.
12. S. I. Hodgetts, M. W. Beilharz, A. A. Scalzo, and M. D. Grounds, "Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or NK1.1+ cells," Cell Transplantation, vol. 9, no. 4, pp. 489-502, 2000.
13. H. Song, M.-J. Cha, B.-W. Song et al., "Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex,"Stem Cells, vol. 28, no. 3, pp. 555-563, 2010.
14. K. Raedschelders, D.M. Ansley, and D. D. Y. Chen, "The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion," Pharmacology & Therapeutics, vol. 133, no. 2, pp. 230-255, 2012.
15. X.-B. Liu, H. Chen, H.-Q. Chen et al., "Angiopoietin-1 preconditioning enhances survival and functional recovery of mesenchymal stem cell transplantation," Journal of Zhejiang University: Science B, vol. 13, no. 8, pp. 616-623, 2012.
16. H. K. Haider and M. Ashraf, "Preconditioning and stem cell survival," Journal of Cardiovascular Translational Research, vol. 3, no. 2, pp. 89-102, 2010.
17. B. S. Fleenor, A. L. Sindler, N. K. Marvi et al., "Curcumin ameliorates arterial dysfunction and oxidative stress with aging," Experimental Gerontology, vol. 48, no. 2, pp. 269-276, 2013.
18. R. Motterlini, R. Foresti, R. Bassi, and C. J. Green, "Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress," Free Radical Biology and Medicine, vol. 28, no. 8, pp. 1303-1312, 2000.
19. A. Barzegar and A. A. Moosavi-Movahedi, "Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin," PLoS ONE, vol. 6, no. 10, Article ID e26012, 2011.
20. A. González-Salazar, E. Molina-Jijón, F. Correa et al., "Curcumin protects from cardiac reperfusion damage by attenuation of oxidant stress and mitochondrial dysfunction," Cardiovascular Toxicology, vol. 11, no. 4, pp. 357-364, 2011.
21. Q. Gu, Y. Cai, C. Huang, Q. Shi, and H. Yang, "Curcumin increases rat mesenchymal stem cell osteoblast differentiation but inhibits adipocyte differentiation," Pharmacognosy Magazine, vol. 8, no. 31, pp. 202-208, 2012.
22. D. R. Ormond, C. Shannon, J. Oppenheim et al., "Stem cell therapy and curcumin synergistically enhance recovery from spinal cord injury," PLoS ONE, vol. 9, no. 2, Article ID e88916, 2014.
23. J. Liu, H. Wang, Y. Wang et al., "The stem cell adjuvant with Exendin-4 repairs the heart after myocardial infarction via STAT3 activation," Journal of Cellular and Molecular Medicine, vol. 18, no. 7, pp. 1381-1391, 2014.
24. J. Liu, H. Wang, Y. Wang et al., "Exendin-4 pretreated adipose derived stem cells are resistant to oxidative stress and improve cardiac performance via enhanced adhesion in the infarcted heart," PLoS ONE, vol. 9, no. 6, Article ID e99756, 2014.
25. K. Ieishi, M. Nomura, T. Kawano et al., "The effect of G-CSF in a myocardial ischemia reperfusion model rat," The Journal of Medical Investigation, vol. 54, no. 1-2, pp. 177-183, 2007.
26. H. Kin, N.-P. Wang, J. Mykytenko et al., "Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-κB translocation and TNFα release," Shock, vol. 29, no. 6, pp. 761-768, 2008.
27. W. Chang, B. W. Song, S. Lim et al., "Mesenchymal stem cells pretreated with delivered Hph-1-Hsp70 protein are protected from hypoxia-mediated cell death and rescue heart functions from myocardial injury," Stem Cells, vol. 27, no. 9, pp.2283-2292, 2009.
28. J. Grossmann, "Molecular mechanisms of 'detachment-induced apoptosis - Anoikis'," Apoptosis, vol. 7, no. 3, pp. 247-260, 2002.
29. D. E. Ingber, "Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology," Circulation Research, vol. 91, no. 10, pp. 877-887, 2002.
30. C. Glass and D. K. Singla, "MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart," The American Journal of Physiology - Heart and Circulatory Physiology, vol. 301, no. 5, pp. H2038-H2049, 2011.
31. B.-H. Jiang and L.-Z. Liu, "Chapter 2 PI3K/PTEN signaling in angiogenesis and tumorigenesis," Advances in Cancer Research, vol. 102, pp. 19-65, 2009.
32. V. Stambolic, A. Suzuki, J. L. de la Pompa et al., "Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN," Cell, vol. 95, no. 1, pp. 29-39, 1998.
33. X.-Z. Zhang, X.-J. Li, and H.-Y. Zhang, "Curcumin's potential to modulate stem cell fate," Trends in Pharmacological Sciences, vol. 30, no. 7, pp. 331-332, 2009.
34. L. Armstrong, O. Hughes, S. Yung et al., "The role of PI3K/AKT, MAPK/ERK and NFκβ signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis," Human Molecular Genetics, vol. 15, no. 11, pp. 1894-1913, 2006.
35. K. Bensaad, A. Tsuruta, M. A. Selak et al., "TIGAR, a p53-inducible regulator of glycolysis and apoptosis," Cell, vol. 126, no. 1, pp. 107-120, 2006.
36. X. Li, W. Xie, C. Xie et al., "Curcumin modulates miR-19/PTEN/AKT/p53 axis to suppress bisphenol A-induced MCF-7 breast cancer cell proliferation," Phytotherapy Research, vol. 28, pp. 1553-1560, 2014.
37. M. Namiecińska, K. Marciniak, and J. Z. Nowak, "VEGF as an angiogenic, neurotrophic, and neuroprotective factor," Postępy Higieny i Medycyny Doświadczalnej, vol. 59, pp. 573-583, 2005.
38. N. Ferrara, H.-P. Gerber, and J. LeCouter, "The biology of VEGF and its receptors," Nature Medicine, vol. 9, no. 6, pp. 669-676, 2003.
39. R. Uemura, M. Xu, N. Ahmad, and M. Ashraf, "Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling," Circulation Research, vol. 98, no. 11, pp. 1414-1421, 2006.